SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: l. euler who wrote (686)7/28/1998 11:57:00 AM
From: topvest  Read Replies (1) of 849
 
Matrictech is planning to submit NMP22 data for screening approval, sometime before the end of the year.

Again, I do not think they will get such approval because the sensitivity of the test is not high enough.

I know little about the Japanese regulatory approval process. However, I do know that the US approval process is very difficult. Getting anything past the involved committee approval process is tortuous, at best, and involves politics, as well as science.

Look for second quarter results sometime Thursday/Friday, or beginning of next week.

topvest
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News